Clinical Characteristics and Coping Strategies of Neoplasms with 2019 Novel Coronavirus Infection

Por Nannan ZHAO, Jie SHI, Lizhong ZENG, Shuanying YANG
Publicado em 2020-04-01

Thoracic perfusion of matrine as an adjuvant treatment improves the control of the malignant pleural effusions

Por Biaoxue, Rong, Shuxia, Ma, Wenlong, Gao, Shuanying, Yang
Publicado no World J Surg Oncol (2015)

Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years’ discoveries and developments

Por Biaoxue, Rong, Xiguang, Cai, Hua, Liu, Shuanying, Yang
Publicado no J Transl Med (2016)

Increased serum amyloid A as potential diagnostic marker for lung cancer: a meta-analysis based on nine studies

Por Biaoxue, Rong, Hua, Liu, Wenlong, Gao, Shuanying, Yang
Publicado no BMC Cancer (2016)

Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion

Por Biaoxue, Rong, Hui, Pan, Wenlong, Gao, Shuanying, Yang
Publicado no Sci Rep (2016)

Overexpression of stathmin promotes metastasis and growth of malignant solid tumors: a systemic review and meta-analysis

Por Biaoxue, Rong, Hua, Liu, Wenlong, Gao, Shuanying, Yang
Publicado no Oncotarget (2016)

Efficacy and safety of icotinib in treating non-small cell lung cancer: a systematic evaluation and meta-analysis based on 15 studies

Por Biaoxue, Rong, Hua, Liu, Wenlong, Gao, Shuanying, Yang
Publicado no Oncotarget (2016)

LINC00668 is Highly Expressed in Lung Squamous Cell Carcinoma and 
Promotes Tumor Cell Migration and Invasion

Por Bo YUAN, Yang CHEN, Jingyan YUAN, Lizhong ZENG, Shuanying YANG
Publicado em 2022-04-01

Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer

Por Biaoxue, Rong, Shuanying, Yang, Wei, Li, Wei, Zhang, Zongjuan, Ming
Publicado em 2012

Differential diagnostic CYFRA 21-1 level for benign and malignant pleural effusions: a meta-analysis in the Chinese population

Por Biaoxue, Rong, Shuanying, Yang, Xiguang, Cai, Wei, Zhang, Wei, Li
Publicado em 2012

Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a...

Por Biaoxue, Rong, Xiguang, Cai, Hua, Liu, Wenlong, Gao, Shuanying, Yang
Publicado no BMC Cancer (2016)

Expression and Bioinformatic Analysis of Ornithine Aminotransferase 
in Non-small Cell Lung Cancer

Por Danfei ZHOU, Xi'an CHENG, Shuanying YANG, Zongjuan MING, Wei LI, Qiuhong ZHANG, Yuping ZHANG
Publicado em 2012-09-01

Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis.

Por Boxuan Liu, Yun Zhao, Jingyan Yuan, Lizhong Zeng, Ruiying Sun, Xia Meng, Shuanying Yang
Publicado em 2017-01-01

Upregulation of Hsp90-beta and annexin A1 correlates with poor survival and lymphatic metastasis in lung cancer patients

Por Biaoxue, Rong, Xiling, Jiang, Shuanying, Yang, Wei, Zhang, Xiguang, Cai, Jinsui, Wang, Min, Zhang
Publicado em 2012

Stathmin overexpression is associated with growth, invasion and metastasis of lung adenocarcinoma

Por Yurong, Lin, Biaoxue, Rong, Wei, Li, Zongjuan, Ming, Hongyang, Shi, Ping, Fang, Wenlong, Gao, Shuanying, Yang, Zongfang, Li
Publicado no Oncotarget (2016)

The role and potential mechanisms of LncRNA-TATDN1 on metastasis and invasion of non-small cell lung cancer

Por Zequn, Niu, Xuemei, Zhang, Wei, Li, Zongjuan, Ming, Yujie, Zhong, Yanli, Hou, Yuping, Zhang, Xia, Meng, Wei, Wang, Wenjing, Deng, Na, Fan, Shuanying, Yang
Publicado no Oncotarget (2016)

Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI

Por Juan Ma, Ying Bai, Mei Liu, Tong Jiao, Yang Chen, Bo Yuan, Boxuan Liu, Lizhong Zeng, Zongjuan Ming, Wei Li, Ruiying Sun, Xia Yang, Shuanying Yang
Publicado em 2022-04-01

Co-Occurring Alterations of ERBB2 Exon 20 Insertion in Non-Small Cell Lung Cancer (NSCLC) and the Potential Indicator of Response to Afatinib

Por Bo Yuan, Jun Zhao, Chengzhi Zhou, Xiumei Wang, Bo Zhu, Minglei Zhuo, Xilin Dong, Jiemei Feng, Cuihua Yi, Yunpeng Yang, Hua Zhang, Wangyan Zhou, Zhengtang Chen, Sheng Yang, Xinghao Ai, Kehe Chen, Xuefan Cui, Difa Liu, Chunmei Shi, Wei Wu, Yanjun Zhang, Lianpeng Chang, Jin Li, Rongrong Chen, Shuanying Yang
Publicado em 2020-05-01